Technologies
Trevi Therapeutics Inc (NASDAQ: TRVI) Has Advanced 145.85% In 2025; Is The Share Price Attractive Enough At $12?
Trevi Therapeutics Inc (NASDAQ:TRVI)’s traded shares stood at 0.77 million during the latest session, with the company’s beta value hitting 0.53. At the last check